Herein we present the case of a patient who developed multiple end-organ damage due to unrecognized and uncontrolled hypertension caused by an aldosterone-producing adrenal adenoma. Clinical and radiological evaluation revealed hypertensive encephalopathy, cardiomyopathy, retinopathy and nephropathy which required hemodialysis. Blood pressure control before surgery was difficult due to renal impairment that precluded the administration of anti-aldosterone drugs. Primary aldosteronism was cured by laparoscopic adrenalectomy and all antihypertensive drugs were suspended.
Introduction
Patients with primary aldosteronism (PA) are at higher risk of cardiovascular morbidity and mortality than patients with primary hypertension and a comparable cardiovascular risk profile [1] . Herein, we present a case of a patient who developed multiple end-organ damage due to unrecognized and uncontrolled hypertension caused by an aldosteroneproducing adrenal adenoma. In particular, the diagnostic work-up and some issues about the choice of an effective antihypertensive therapy are described.
Timeline

Timeline Events
Before hospitalization 
Case presentation
A 42-year-old white man, with a 1-year history of dizziness, headache, earache, and vomiting was hospitalized for a diagnostic work-up. His blood pressure (BP) was never measured in the preceding months. He took over the counter nimesulide for 6 months (on average 100 mg tid) and reported habitual use of recreational drugs (cocaine) and alcohol (on average 110 gr/d). Physical examination was unremarkable apart from a BP of 220/100 mm Hg and laboratory tests showed severe hypokalemia and impaired renal function ( Table 1 ) .
Assessment and diagnosis
Brain magnetic resonance showed findings consistent with hypertensive encephalopathy ( Fig. 1 ) whereas echocardiography with hypertensive cardiomyopathy in dilatative phase ( Fig. 2 ) . At ultrasound, kidneys appeared of normal size and morphology and no renal artery stenosis was detected. Ophthalmoscopy revealed malignant hypertensive retinopathy (left eye; Fig. 3 ). Abdominal magnetic resonance identified a 22 mm left adrenal solid mass with typical features of an adenoma ( Fig. 4 ) , thus a presumptive diagnosis of PA due to an aldosterone producing adenoma was made, supported by the extremely high levels of aldosterone and aldosterone-to-renin ratio ( ( Fig. 5 ) .
The postoperative period was uneventful and the patient was discharged with amlodipine 10 mg/d, atenolol 25 mg/d, doxazosin 2 mg/d, and furosemide 100 mg/d. All drugs were progressively discontinued due to the normalization of BP.
The effectiveness of surgery is proved not just by the withdrawal of all the antihypertensive drugs but also by the partial regression of cardiac structural abnormalities ( Fig. 2 ) . The patient was still on hemodialysis and work-up for renal transplantation began.
Discussion
PA usually leads to the development of moderate to severe hypertension [2] but with a greater cardiovascular morbidity and mortality than patients with primary hypertension and comparable cardiovascular risk profile suggesting that aldosterone excess prompts additional fibrosis and remodeling in target organs [1, 3] . Furthermore, aldosterone hypersecretion can lead to significant functional changes in the kidney, such as an increase in renal perfusion pressure, which are largely reversible in the earliest stages of the disease but later can result in nephroangiosclerosis and progressive kidney injury [4] . Cardiovascular and renal complications in patients with PA generally require many years to occur but the patient described herein, despite his relatively young age, developed multiple end-organ damage at presentation. Thus, we can speculate that either his clinical history was longer then recorded, or that hypertension and PA were particularly severe or that other factors such as cocaine, alcohol, and nonsteroidal anti-inflammatory drugs abuse can have contributed. As known, chronic cocaine abuse can be related with an increase in left ventricular mass index [5] and diastolic dysfunction [6] and nonsteroidal anti-inflammatory drugs abuse can have harmful effects on renal function that may cause disease progression in patients with pre-existing kidney disease [7] . Another interesting issue is the possible confounding effects of plasma renin and aldosterone given by the therapy on one side and nephroangiosclerosis on the other. It is worth noting that in the first dosage aldosterone was extremely high but renin not correspondently inhibited probably due to the stimulus derived by the chronic kidney disease [4] or the relative patient's dehydration. After three weeks of antihypertensive therapy, including beta-blockers (renin inhibitor), furosemide (renin stimulator) and amlodipine (slight renin stimulator) other than abundant hydration (renin inhibitor) [1] but still in a situation of nephroangiosclerosis (renin stimulator) [4] , aldosterone was almost normalized and renin persisted not suppressed. This underlines the importance of the careful consideration of the different factors that can either inhibit or enhance renin and aldosterone production to pursue a correct diagnosis. Of note, a second line test to rule out primary aldosteronism, due to concomitant renal comorbidity, was not advisable.
Despite the initial institution of a quadruple antihypertensive therapy, the patient presented resistant hypertension. Furthermore, due to the development of end stage renal disease, administration of mineralocorticoid receptor antagonists, the drugs of choice in the medical treatment of PA, was not possible before hemodialysis [1] . Some studies show that anti-aldosterone drugs can be administered safely in patients undergoing hemodialysis [8, 9] , but the cure of hypertension after aldosterone removal did not require its use herein. Moreover, satisfactory BP control, until surgery, was obtained by replacing carvedilol with atenolol. In general, nonlipophilic beta-blockers, such as atenolol, are excreted unchanged in the urine [10] whereas lipophilic agents, such as carvedilol, are subject to extensive first-pass metabolism dependent on cy- tochrome P450 2D6 enzyme. The interindividual differences in isoenzyme activity may considerably affect metabolic rate of lipophilic beta-blockers resulting in ineffective blood levels in some rapid or ultra-rapid metabolizers [11] . Therefore, in this patient, the much more reliable bioavailability of hydrophilic beta-blockers could explain the greater antihypertensive effect of atenolol compared to carvedilol.
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